SJFT Performance, Inhibitory Control, and Attention in Young Judokas

August 28, 2026 updated by: Muhammed Sıddık Çemç, Bogazici University

The Relationship Between Special Judo Fitness Test (SJFT) Performance and Inhibitory Control and Selective Attention in Young Judokas

This study will examine the relationship between judo-specific physical fitness and cognitive performance in young male judo athletes and will evaluate the immediate effects of the Special Judo Fitness Test (SJFT) on attention and inhibitory control. Licensed male judo athletes who train regularly at least three days per week will be compared with male participants who do not actively participate in sports.

Judo athletes will complete a standardized warm-up followed by the SJFT, a judo-specific high-intensity fitness test involving repeated throws performed over three short exercise periods separated by brief rest intervals. Heart rate will be measured immediately after the SJFT and again one minute later.

Cognitive performance will be assessed using a computerized Flanker Task, which will measure reaction time and response accuracy while participants respond to relevant visual information and ignore distracting information. Judo athletes will complete the Flanker Task approximately one minute before and one minute after the SJFT. Participants in the control group will complete the same cognitive assessment twice over a similar time interval without performing the physical exercise.

The study will aim to determine whether judo-specific physical fitness and judo experience are associated with attention and inhibitory control and whether a single high-intensity judo-specific exercise session will produce an immediate change in cognitive performance.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Türkiye
      • Istanbul, Türkiye, Turkey (Türkiye), 34342
        • Boğaziçi University
        • Contact:
          • Muhammed Sıddık Çemç, Dr.
          • Phone Number: +90 537 016 29 25
          • Email: mscemc@gmail.com
        • Contact:
        • Principal Investigator:
          • Muhammed Sıddık Çemç, Dr.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

Male participants residing in Istanbul. For the judo group: licensed judo athletes who regularly participate in judo training at least three days per week.

For the control group: individuals who are not actively involved in any sports branch.

Right-handed participants, as determined using the Edinburgh Handedness Inventory.

Participants who provide informed consent to participate in the study.

Exclusion Criteria:

History of visual impairment. History of neurological disorders. History of psychiatric disorders. History of cardiovascular disease. Current medication use.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Judo Group
Participants in the judo group will complete a standardized warm-up followed by the Special Judo Fitness Test (SJFT). Cognitive performance will be assessed using the Flanker Task approximately one minute before and one minute after the SJFT.
The Special Judo Fitness Test is a judo-specific high-intensity exercise test consisting of three exercise periods: 15 seconds, 30 seconds, and 30 seconds, with 10-second rest intervals between periods. During the test, the participant will perform as many ippon-seoi-nage throws as possible using two partners positioned six meters apart.
No Intervention: Control Group
Participants in the control group will not perform the SJFT or any other exercise intervention. They will complete the Flanker Task twice over a similar time interval while remaining at rest.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Flanker Task Correct Responses
Time Frame: Approximately 1 minute before and 1 minute after the intervention
Response accuracy will be assessed using a computerized Flanker Task. The number of correct responses will be recorded separately for congruent and incongruent trials. Higher numbers of correct responses indicate greater response accuracy.
Approximately 1 minute before and 1 minute after the intervention
Change in Flanker Task Reaction Time
Time Frame: Approximately 1 minute before and 1 minute after the intervention
Reaction time will be assessed for congruent and incongruent trials using a computerized Flanker Task. Lower reaction times indicate faster cognitive responses.
Approximately 1 minute before and 1 minute after the intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

September 15, 2026

Primary Completion (Estimated)

October 15, 2026

Study Completion (Estimated)

October 30, 2026

Study Registration Dates

First Submitted

August 28, 2026

First Submitted That Met QC Criteria

August 28, 2026

First Posted (Actual)

September 1, 2026

Study Record Updates

Last Update Posted (Actual)

September 1, 2026

Last Update Submitted That Met QC Criteria

August 28, 2026

Last Verified

August 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • E-84391427-050.04-297820

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be shared because no formal data-sharing plan has been established for this study. Study findings will be reported in aggregate form in scientific publications and presentations.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe